Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: U19AI149680
National Institute of Allergy and Infectious Diseases
Grant: U19AI117950
National Institute of Allergy and Infectious Diseases
Grant: U19AI082628
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI126620
National Institute of Allergy and Infectious Diseases
Grant: UM1AI164570
Adaptimmune
Grant: internal funding
NIAID NIH HHS
Grant: P30 AI045008
NCI NIH HHS
Grant: P30 CA016520
National Institutes of Health
Grant: 5P30AI045008-10
Core--Immunology Facility
National Institutes of Health
Grant: 5UM1AI126620-05
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
National Institutes of Health
Grant: 1U19AI082628-01
Administrative Core
National Institutes of Health
Grant: 5U19AI117950-02
Engineering T cells to Provide Durable Control of HIV-1 Replication
National Institutes of Health
Grant: 5U19AI149680-03
Engineering T cells to Provide Durable Control of HIV-1 Replication
National Institutes of Health
Grant: 2P30CA016520-35
Abramson Cancer Center Support Grant
National Institutes of Health
Grant: 5UM1AI164570-03
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
FWCI
1.04
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals